Leading the way to non-invasive neonatal therapies

ONY Biotech is a family-focused neonatology pharmaceutical company creating therapies that improve outcomes for premature babies and their families.

About us

For babies with respiratory distress syndrome, tomorrow is made possible by Infasurf® (calfactant).

Infasurf® (calfactant) helps prevent and treat respiratory distress syndrome in newborns, restoring surface activity in the lungs and quickly improving respiration.

Learn more

Latest News

Leading the Way in Neonatal Therapies

February 26, 2019

Buffalo Business First speaks to ONY Biotech about the company’s continued strides toward creating innovative therapies to improve outcomes...

Just Chillin’

June 28, 2018

Summer is in full swing here in Buffalo and wherever there is hot weather, ice cream is not far...

Walking Among Super Heroes

May 12, 2018

To commemorate Women and Children’s Hospital’s big move last year, local radio station Kiss 98.5 hosted the first annual...

All News